Mucormycosis as a complication of COVID-19 coronavirus infection: eye symptoms
COVID-19 causes an immunosuppressive condition and increases the risk of secondary infections, including fungal diseases such as mucormycosis (MM), so doctors should be aware of the possibility of MM development in COVID-19 patients. Since no specific complaints or clinical symptoms exist and the di...
Saved in:
| Main Authors: | A. E. Babushkin, L. I. Gilemzianova, I. P. Ponomarev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Real Time Ltd
2024-07-01
|
| Series: | Российский офтальмологический журнал |
| Subjects: | |
| Online Access: | https://roj.igb.ru/jour/article/view/1499 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19–associated central nervous system mucormycosis
by: Anjali Mishra, et al.
Published: (2021-01-01) -
Mucormycosis Associated with Global Coronavirus Disease-19 Pandemic: A Study of Fungal Profile from a Tertiary Health-care Center
by: Snigdha Purohit, et al.
Published: (2024-01-01) -
Non-COVID-19 Cutaneous Mucormycosis from a Plastic Surgical Perspective
by: Vimalendu Brajesh, et al.
Published: (2023-08-01) -
Successful treatment of a patient with a severe course of a new coronavirus infection and purulent complications after left-sided hemicolectomy under the immunosuppressive therapy
by: G. G. Nakopiya, et al.
Published: (2023-10-01) -
Cutaneous mucormycosis: Unveiling rare manifestations
by: Jyoti Jindal, et al.
Published: (2025-06-01)